Growth Metrics

Quest Diagnostics (DGX) Gross Profit (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Gross Profit for 17 consecutive years, with $910.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 6.06% to $910.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Dec 2025, up 12.98% year-over-year, with the annual reading at $3.7 billion for FY2025, 12.98% up from the prior year.
  • Gross Profit hit $910.0 million in Q4 2025 for Quest Diagnostics, down from $949.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.1 billion in Q3 2021 to a low of $736.0 million in Q4 2023.
  • Historically, Gross Profit has averaged $880.2 million across 5 years, with a median of $860.5 million in 2024.
  • Biggest five-year swings in Gross Profit: surged 98.19% in 2021 and later fell 26.12% in 2022.
  • Year by year, Gross Profit stood at $1.0 billion in 2021, then dropped by 26.12% to $758.0 million in 2022, then dropped by 2.9% to $736.0 million in 2023, then rose by 16.58% to $858.0 million in 2024, then rose by 6.06% to $910.0 million in 2025.
  • Business Quant data shows Gross Profit for DGX at $910.0 million in Q4 2025, $949.0 million in Q3 2025, and $943.0 million in Q2 2025.